Ligands of EGFR have been shown to be secreted by different types of cancer cells following IR, resulting in the autocrine activation of the EGFR/Ras/MEK/MAPK pathways which can protect irradiated cells from IR-induced death (16–18). This evidence concerns the gene EGFR and cancer.